false 0000310158 0000310158 2023-11-21 2023-11-21 0000310158 us-gaap:CommonStockMember 2023-11-21 2023-11-21 0000310158 mrk:Sec0.500NotesDue2024Member 2023-11-21 2023-11-21 0000310158 mrk:Sec1.875NotesDue2026Member 2023-11-21 2023-11-21 0000310158 mrk:Sec2.500NotesDue2034Member 2023-11-21 2023-11-21 0000310158 mrk:Sec1.375NotesDue2036Member 2023-11-21 2023-11-21 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of

the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported) November 28, 2023 (November 21, 2023)

 

Merck & Co., Inc.

(Exact name of registrant as specified in its charter)

 

New Jersey

(State or other jurisdiction

of incorporation)

 

1-6571

(Commission

File Number)

 

22-1918501

(I.R.S Employer

Identification No.)

 

126 East Lincoln Avenue, Rahway, NJ

(Address of principal executive offices)

 

07065

(Zip Code)

 

(Registrant’s telephone number, including area code) (908) 740-4000

 

Not Applicable

(Former name, former address and former fiscal year, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class  Trading Symbol(s)  Name of each exchange on which registered
       
Common Stock ($0.50 par value)  MRK  New York Stock Exchange
0.500% Notes due 2024  MRK 24  New York Stock Exchange
1.875% Notes due 2026  MRK/26  New York Stock Exchange
2.500% Notes due 2034  MRK/34  New York Stock Exchange
1.375% Notes due 2036  MRK 36A  New York Stock Exchange

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company  ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ¨

 

 

 

 

 

 

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

(b)    Resignation of Certain Officers

 

On November 21, 2023, Rita Karachun, Senior Vice President Finance – Global Controller and principal accounting officer of Merck & Co., Inc. (the “Company”), gave notice of her intention to resign from this position effective December 4, 2023. Ms. Karachun plans to retire from the Company in 2024. Ms. Karachun’s resignation is not due to any disagreement with the Company with respect to any matter relating to the Company’s operations, policies or practices.

 

(c)    Appointment of Certain Officers

 

On November 28, 2023, the Board of Directors (the “Board”) of the Company elected Dalton E. Smart III to serve as Senior Vice President Finance – Global Controller of the Company, effective December 4, 2023, making him the Company’s principal accounting officer.

 

Mr. Smart, 57 years old, has served as Assistant Controller of the Company since September 2023. Prior to his appointment as Assistant Controller of the Company, Mr. Smart served the Company as Vice President – Internal Audit from March 2015 to August 2023 and Executive Director, Audit from November 2009 to February 2015. Mr. Smart has no arrangements or understandings with any other person pursuant to which he was elected as an officer, nor does he have a relationship or related transaction with the Company that would require disclosure pursuant to Item 404(a) of Regulation S-K of the Securities and Exchange Commission in connection with his appointment. There are no family relationships between Mr. Smart and any of the Company’s executive officers or directors.

 

In connection with Mr. Smart’s appointment as Senior Vice President Finance – Global Controller, effective December 4, 2023, Mr. Smart will receive compensation in a manner consistent with the Company’s compensation of its Senior Vice Presidents.

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    Merck & Co., Inc.
     
Date: November 28, 2023 By: /s/ Kelly E. W. Grez
    Kelly E. W. Grez
Corporate Secretary

 

 

 

v3.23.3
Cover
Nov. 21, 2023
Document Information [Line Items]  
Document Type 8-K
Amendment Flag false
Document Period End Date Nov. 21, 2023
Entity File Number 1-6571
Entity Registrant Name Merck & Co., Inc.
Entity Central Index Key 0000310158
Entity Tax Identification Number 22-1918501
Entity Incorporation, State or Country Code NJ
Entity Address, Address Line One 126 East Lincoln Avenue
Entity Address, City or Town Rahway
Entity Address, State or Province NJ
Entity Address, Postal Zip Code 07065
City Area Code 908
Local Phone Number 740-4000
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Common Stock  
Document Information [Line Items]  
Title of 12(b) Security Common Stock ($0.50 par value)
Trading Symbol MRK
Security Exchange Name NYSE
0.500% Notes due 2024  
Document Information [Line Items]  
Title of 12(b) Security 0.500% Notes due 2024
Trading Symbol MRK 24
Security Exchange Name NYSE
1.875% Notes due 2026  
Document Information [Line Items]  
Title of 12(b) Security 1.875% Notes due 2026
Trading Symbol MRK/26
Security Exchange Name NYSE
2.500% Notes due 2034  
Document Information [Line Items]  
Title of 12(b) Security 2.500% Notes due 2034
Trading Symbol MRK/34
Security Exchange Name NYSE
1.375% Notes due 2036  
Document Information [Line Items]  
Title of 12(b) Security 1.375% Notes due 2036
Trading Symbol MRK 36A
Security Exchange Name NYSE

Merck (NYSE:MRK)
Graphique Historique de l'Action
De Jan 2024 à Fév 2024 Plus de graphiques de la Bourse Merck
Merck (NYSE:MRK)
Graphique Historique de l'Action
De Fév 2023 à Fév 2024 Plus de graphiques de la Bourse Merck